In the United States, annual prescription drug spend accounts for ~10% of all health spending. Decreases in affordability in prescription drug costs make it more difficult for Americans to secure the drugs they need to be healthy, resulting in poorer overall health, which ends up costing society more in the long run – a vicious cycle The pressure of increased drug costs is also felt by government programs like Medicare and Medicaid. Capital Rx is the fast-growing pharmacy benefits manager that utilizes technology to introduce transparency to and make sense of this opaque market. The startup has built the first-of-its-kind Enterprise Pharmacy Platform to unify all facets of the pharmacy benefits management process into a single system, leading to never-before-found efficiency in pricing and improved patient outcomes. AlleyWatch caught up with CEO AJ Loiacono to learn more about the state of the pharmacy benefits management market, the company’s novel approach to making drugs more accessible, the company’s future plans, and recent round of funding from Transformation Capital and Edison Partners.